These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7495409)
1. [The effect of calcium 2+ ions on the decomposition of canine and human fibrin(ogen) by (human) plasmin]. Wolling H; Mischke R Berl Munch Tierarztl Wochenschr; 1995 Oct; 108(10):373-9. PubMed ID: 7495409 [TBL] [Abstract][Full Text] [Related]
2. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain. Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274 [TBL] [Abstract][Full Text] [Related]
3. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma. Carroll RC; Lockhart MS; Taylor FB J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329 [TBL] [Abstract][Full Text] [Related]
4. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis. Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005 [TBL] [Abstract][Full Text] [Related]
6. [Preparation and separation of milligram amounts of canine fibrin(ogen) degradation products (fdp) X, Y, D and E]. Wolling H; Mischke R Berl Munch Tierarztl Wochenschr; 1995 Nov; 108(11):421-6. PubMed ID: 8593135 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains. Soria J; Soria C; Samama M; Tabori S; Kehl M; Henschen A; Nieuwenhuizen W; Rimon A; Tatarski I Thromb Haemost; 1987 Jun; 57(3):310-3. PubMed ID: 2958955 [TBL] [Abstract][Full Text] [Related]
8. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin. Krajewski T; Nowak P; Cierniewski C Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448 [TBL] [Abstract][Full Text] [Related]
9. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. Plow E; Edgington TS J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160 [TBL] [Abstract][Full Text] [Related]
10. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond. Bini A; Itoh Y; Kudryk BJ; Nagase H Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941 [TBL] [Abstract][Full Text] [Related]
11. Protective effect of divalent cations in the plasmin degradation of fibrinogen. Dang CV; Bell WR; Ebert RF; Starksen NF Arch Biochem Biophys; 1985 May; 238(2):452-7. PubMed ID: 3158281 [TBL] [Abstract][Full Text] [Related]
12. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity. Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083 [TBL] [Abstract][Full Text] [Related]
13. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Pfitzner SA; Dempfle CE; Matsuda M; Heene DL Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis]. Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y). Nieuwenhuizen W; Voskuilen M; Hermans J Biochim Biophys Acta; 1982 Nov; 708(3):313-6. PubMed ID: 6216917 [TBL] [Abstract][Full Text] [Related]
16. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats. Nieuwenhuizen W; Emeis JJ; Vermond A Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343 [TBL] [Abstract][Full Text] [Related]
18. gamma-dimerization, alpha-polymerization, and plasmin degradation of human fibrin. Effect of various inhibitors of factor XIII on the patterns in SDS-electrophoresis and crossed immunoelectrophoresis. Feddersen JC; Gormsen J Thromb Haemost; 1976 Aug; 36(1):27-36. PubMed ID: 137555 [TBL] [Abstract][Full Text] [Related]
19. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Siebenlist KR; Meh DA; Mosesson MW Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711 [TBL] [Abstract][Full Text] [Related]
20. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa. Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]